DukeSpace

A Strategy To Advance the Evidence Base in Palliative Medicine: Formation of a Palliative Care Research Cooperative Group

DukeSpace

Show simple item record

dc.contributor.author Abernethy, Amy en_US
dc.contributor.author Wheeler, Jane en_US
dc.contributor.author Zafar, Yousuf en_US
dc.date.accessioned 2011-04-15T16:46:31Z
dc.date.available 2011-04-15T16:46:31Z
dc.date.issued 2010 en_US
dc.identifier.citation Abernethy,Amy P.;Aziz,Noreen M.;Basch,Ethan;Bull,Janet;Cleeland,Charles S.;Currow,David C.;Fairclough,Diane;Hanson,Laura;Hauser,Joshua;Ko,Danielle;Lloyd,Linda;Morrison,R. Sean;Otis-Green,Shirley;Pantilat,Steve;Portenoy,Russell K.;Ritchie,Christine;Rocker,Graeme;Wheeler,Jane L.;Zafar,S. Yousuf;Kutner,Jean S.. 2010. A Strategy To Advance the Evidence Base in Palliative Medicine: Formation of a Palliative Care Research Cooperative Group. Journal of palliative medicine 13(12): 1407-1413. en_US
dc.identifier.issn 1096-6218 en_US
dc.identifier.uri http://hdl.handle.net/10161/3239
dc.description.abstract Background: Palliative medicine has made rapid progress in establishing its scientific and clinical legitimacy, yet the evidence base to support clinical practice remains deficient in both the quantity and quality of published studies. Historically, the conduct of research in palliative care populations has been impeded by multiple barriers including health care system fragmentation, small number and size of potential sites for recruitment, vulnerability of the population, perceptions of inappropriateness, ethical concerns, and gate-keeping. Methods: A group of experienced investigators with backgrounds in palliative care research convened to consider developing a research cooperative group as a mechanism for generating high-quality evidence on prioritized, clinically relevant topics in palliative care. Results: The resulting Palliative Care Research Cooperative (PCRC) agreed on a set of core principles: active, interdisciplinary membership; commitment to shared research purposes; heterogeneity of participating sites; development of research capacity in participating sites; standardization of methodologies, such as consenting and data collection/management; agile response to research requests from government, industry, and investigators; focus on translation; education and training of future palliative care researchers; actionable results that can inform clinical practice and policy. Consensus was achieved on a first collaborative study, a randomized clinical trial of statin discontinuation versus continuation in patients with a prognosis of less than 6 months who are taking statins for primary or secondary prevention. This article describes the formation of the PCRC, highlighting processes and decisions taken to optimize the cooperative group's success. en_US
dc.language.iso en_US en_US
dc.publisher MARY ANN LIEBERT INC en_US
dc.relation.isversionof doi:10.1089/jpm.2010.0261 en_US
dc.subject controlled-trial en_US
dc.subject clinical-trials en_US
dc.subject statin therapy en_US
dc.subject cancer en_US
dc.subject population en_US
dc.subject atorvastatin en_US
dc.subject prevalence en_US
dc.subject prevention en_US
dc.subject risk en_US
dc.subject pain en_US
dc.subject health care sciences & services en_US
dc.title A Strategy To Advance the Evidence Base in Palliative Medicine: Formation of a Palliative Care Research Cooperative Group en_US
dc.type Article en_US
dc.description.version Version of Record en_US
duke.date.pubdate 2010-12-0 en_US
duke.description.endpage 1413 en_US
duke.description.issue 12 en_US
duke.description.startpage 1407 en_US
duke.description.volume 13 en_US
dc.relation.journal Journal of palliative medicine en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record